RSC Advances
Paper
7.03 (d, 3JHH ¼ 6.8 Hz, 2H, Harom), 6.58 (s, 1H, Hpz), 5.31 (s, 2H, analysis; anal. calcd for C48H40Cl2N4O4Pd: C, 63.06; H, 4.41; N,
H
CH ). 13C{1H} NMR (100 MHz, CDCl3, 30 ꢀC) (ppm) ¼ 150.9; 6.13% found C, 63.18; H 4.71 N, 5.83%.
2
145.4; 137.7; 133.4; 130.6; 128.8; 128.7; 128.4; 128.3; 127.5;
Synthesis of [{bis(methyl 4-((3,5-di-tert-butyl-1H-pyrazol-1-
127.4; 126.9; 126.8; 126.7; 103.7; 53.2: ESI-MS [M + H]+ ¼ 311.15 yl)methyl)benzoate)}-palladium(II) chloride] (6). Into a Schlenk
(100%). Elemental analysis; anal. calcd for C22H18N2: C, 85.13; tube, 200.00 mg of methyl 4-((3,5-di-tert-butyl-1H-pyrazol-1-yl)
H, 5.85; N, 9.03%, found C, 85.40; H, 5.65; N, 9.41%.
methyl)benzoate (0.61 mmol) was added to 78.990 mg (0.30
Synthesis of 1-benzyl-3,5-di-tert-butyl-1H-pyrazole (4). Into mmol) of [PdCl2(MeCN)2] using 5 mL of DCM as solvent. The
a round bottom ask containing 20 mL acetonitrile, 62.500 mg reaction mixture was then stirred for 24 h under argon at room
(1.11 mmol) of KOH was added and the mixture was stirred for temperature. The solvent was reduced in vacuo until the crude
10 minutes. 100.00 mg (0.55 mmol) of 3,5-di-tert-butyl-1H-pyr- product began to precipitate. Hexane 5 mL was then added drop
azole was added and the reaction mixture was stirred for an wise until the product completely precipitated from solution.
additional 20 minutes. Benzyl bromide 114.32 mg (0.67 mmol) The precipitate was ltered off and washed with 2 ꢁ 5 mL
was added slowly over an hour, aer which the reaction mixture hexane and dried under vacuum for 6 h in order to obtain the
ꢀ
was reuxed at 85 C for 24 h. A precipitate formed over time product. Appearance yellow powder, (184.24 mg, 73%). Solu-
which was ltered off. The residue was collected and the solvent bility: soluble in chloroform, DCM, partially soluble in xylene
evaporated to give the crude product. The product was puried and toluene, insoluble in hexane, diethylether, water and
by passing through a silica packed column and eluted with 3 : 7 methanol. Melting point range 241 ꢀC (decomposed without
1
hexane : diethylether mixture. The second band was collected melting). FT-IR (nmax/cmꢂ1): 1716 (C]O). H NMR (400 MHz,
and identied as the product aer TLC comparison with the CDCl3, 30 ꢀC) (ppm) ¼ 8.10 (d, JHH ¼ 8 Hz, 2H, Harom), 8.05 (d,
starting materials. The solvent was then removed by rotary JHH ¼ 7.6 Hz, 2H, Harom), 7.21 (d, JHH ¼ 8 Hz, 2H, Harom), 7.06 (d,
evaporation to obtain the product. Appearance; white crystals JHH ¼ 8 Hz, 2H, Harom), 6.02 (m, 6H, HCH , Hpz), 3.93 (s, 3H,
2
t
t
(yield ¼ 110.10 mg, 73%). Solubility: soluble in chloroform,
HCH ), 3.88 (s, 3H, HCH ), 1.93 (s, H Bu, 6H), 1.89 (s, H Bu, 1H),
3
3
t
t
t
insoluble in water at room temperature. Solubility: soluble in 1.81 (s, H Bu, 6H), 1.61 (s, H Bu, 2H), 1.54 (s, H Bu, 3H), 1.29 (s,
t
t
t
t
chloroform, methanol, DCM, hexane and diethyl ether, insol-
H Bu, 1H), 1.24 (s, H Bu, 7H), 1.22 (s, H Bu, 7H), 1.17 (s, H Bu, 3H),
uble in water. Melting point range 60–62 ꢀC. FT-IR (nmax/cmꢂ1): 13C{1H} NMR (100 MHz, CDCl3, 30 ꢀC) (ppm) ¼ 167.3; 167.2;
1
ꢀ
1456 (C]N). H NMR (400 MHz, CDCl3, 30 C) (ppm) ¼ 7.25 167.1; 167.0; 165.5; 160.9; 157.2; 153.4; 144.2; 141.9; 141.7;
3
3
3
(t, JHH ¼ 5.6 Hz, JHH ¼ 9.2 Hz, 3H, Harom), 6.85 (d, JHH
¼
130.7; 130.6; 130.5; 130.3; 130.2; 130.1; 130.0; 129.9; 129.7;
7.2 Hz 2H, Harom), 5.89 (s, 1H, Hpz), 5.45 (s, 2H, HCH ), 1.29 127.2; 126.9; 125.8; 105.4; 105.1; 56.6; 51.9; 33.0; 32.8; 32.3; 31.8;
2
(s, 9H, H Bu), 1.23 (s, 9H, H Bu). 13C{1H} NMR (100 MHz, CDCl3, 31.7; 31.6; 31.5; 31.4; 31.3; 31.2; 30.5; 30.3; 29.9; ESI-MS [M]+ ¼
t
t
ꢀ
30 C) (ppm) ¼ 160.3; 151.2; 139.2; 128.3; 128.1; 126.7; 126.5; 835.28 (40%). Elemental analysis; anal. calcd for C40H56Cl2N4-
125.8; 100.1; 54.1; 31.9; 30.3; ESI-MS [M + H]+ ¼ 271.21; O4Pd: C, 57.59; H, 6.77, N, 6.72% found C, 57.06; H, 6.77; N,
elemental analysis; anal. calcd for C18H26N2: C, 79.95; H, 6.69%.
9.69; N, 10.36%, found C, 80.08; H, 9.34; N 10.14%.
Synthesis of [{bis(1-benzyl-3,5-diphenyl-1H-pyrazole)}-palla-
Synthesis of [{bis(methyl 4-((3,5-diphenyl-1H-pyrazol-1-yl) dium(II) chloride] (7). Into a Schlenk tube, 100.00 mg of 1-
methyl)benzoate)}-palladium(II) chloride] (5). Into a Schlenk benzyl-3,5-diphenyl-1H-pyrazole (0.32 mmol) was added to
tube, 200.00 mg of methyl 4-((3,5-diphenyl-1H-pyrazol-1-yl) 41.760 mg (0.1609 mmol) of [PdCl2(MeCN)2] using 5 mL of DCM
methyl)benzoate (0.54 mmol) was added to 70.417 mg (0.27 as solvent. The reaction mixture was then stirred for 24 h under
mmol) of [PdCl2(MeCN)2] using 5 mL of DCM as solvent. The argon at room temperature. The solvent was reduced in vacuo
reaction mixture was then stirred for 24 h under argon at room until the crude product began to precipitate. Diethylether 5 mL
temperature. The solvent was reduced in vacuo until the crude was then added drop wise until the product completely
product began to precipitate. Hexane 5 mL was then added precipitated from solution. The precipitate was ltered off and
drop-wise until the product completely precipitated from solu- washed with 2 ꢁ 5 mL diethyl ether and dried under vacuum for
tion. The precipitate was ltered off and washed with 2 ꢁ 5 mL 6 h in order to obtain the product. Appearance yellow powder,
hexane and dried under vacuum for 6 h in order to obtain the (71.211 mg, 55%). Solubility: soluble in chloroform and DCM,
product. Appearance yellow powder, (189.11 mg, 76%). Solu- partially soluble in xylene and toluene, insoluble in water,
bility: partially soluble in chloroform, DCM, xylene and toluene, diethyl ether, methanol and hexane. Melting point range 250–
insoluble in methanol, water, hexane and diethyl ether. Melting 251 ꢀC. FT-IR (nmax/cmꢂ1): 1639 (C]N). 1H NMR (400 MHz,
ꢀ
ꢀ
point range 275 C (decompose without melting). FT-IR (nmax
/
CDCl3, 30 C) (ppm) ¼ 8.20 (d, JHH ¼ 7.2 Hz, 2H, Harom), 7.29–
cmꢂ1): 1713 (C]O). 1H NMR (400 MHz, CDCl3, 30 ꢀC) (ppm) ¼ 7.13 (m, 9H, Harom), 6.99 (d, JHH ¼ 7.2 Hz, 2H, Harom), 6.94 (t, JHH
1
8.15 (d, JHH ¼ 6.8 Hz, 2H, Harom), 7.92(d, JHH ¼ 8 Hz, 2H, Harom), ¼ 8 Hz, JHH ¼ 7.6 Hz, 2H, Harom), 6.30 (s, Hpz, 1H), 6.10 (s, HCH
,
2
7.33–7.28 (m, 6H, Harom), 6.99 (d, JHH ¼ 5.6 Hz, 4H, Harom), 6.37 2H); 13C{1H} NMR (100 MHz, CDCl3, 30 ꢀC) (ppm) ¼ 155.3;
(s, Hpz, 1H), 6.16 (s, HCH , 2H), 3.90 (s, HCH , 3H); 13C{1H} NMR 149.1; 137.3; 131.0; 129.1; 129.0; 128.9; 128.8; 128.7; 128.6;
2
3
(100 MHz, CDCl3, 30 ꢀC) (ppm) ¼ 167.4, 156.2; 149.9; 138.3; 128.5; 128.4; 128.3; 128.2; 110.1; 56.4; ESI-MS [M + Na]+ ¼ 823.12
131.8; 129.4; 129.2; 128.9; 128.8; 128.7; 128.5; 128.4; 128.3; (50%); [M ꢂ Cl]+ ¼ 765.17 (50%); [M ꢂ 2Cl]+ ¼ 725.18 (5%)
128.0; 127.9; 105.1; 57.1; 52.1; ESI-MS [M]+ ¼ 913.15 (10%); [M ꢂ elemental analysis; anal. calcd for C44H36Cl2N4Pd: C, 66.22; H,
Cl]+ ¼ 878.18 (5%); [M ꢂ 2Cl]+ ¼ 840.21 (5%); elemental 4.55, N, 7.02% found C, 66.46; H, 4.51; N, 6.78%.
13828 | RSC Adv., 2018, 8, 13826–13834
This journal is © The Royal Society of Chemistry 2018